Investigation of sex-based differences in the immunotoxicity of silver nanoparticles
Brandon Canup,Paul Rogers,Angel Paredes,Wimolnut Manheng,Beverly Lyn-Cook,Tariq Fahmi,Brandon CanupPaul RogersAngel ParedesWimolnut ManhengBeverly Lyn-CookTariq Fahmia Division of Biochemical Toxicology,Office of Research,National Center for Toxicological Research,U.S. Food and Drug Administration,Jefferson,AR,USAb Division of Bioinformatics and Biostatistics,Office of Research,National Center for Toxicological Research,U.S. Food and Drug Administration,Jefferson,AR,USAc Nanotechnology Core Facility,Office of Scientific Coordination,National Center for Toxicological Research,U.S. Food and Drug Administration,Jefferson,AR,USAd Division of Hematology Oncology Toxicology,Office of Oncologic Diseases,Center for Drug Evaluation and Research,U.S. Food and Drug Administration,Silver Spring,MD,USA
DOI: https://doi.org/10.1080/17435390.2024.2323070
2024-03-07
Nanotoxicology
Abstract:The growing application of silver nanoparticles (AgNPs) in consumer, healthcare, and industrial products has raised concern over potential health implications due to increasing exposure. The evaluation of the immune response to nanomaterials is one of the key criteria to assess their biocompatibility. There are well-recognized sex-based differences in innate and adaptive immune responses. However, there is limited information available using human models. The aim was to investigate the potential sex-based differences in immune functions after exposure to AgNPs using human peripheral blood mononuclear cells (PBMCs) and plasma from healthy donors. These functions include inflammasome activation, cytokine expression, leukocyte proliferation, chemotaxis, plasma coagulation, and complement activation. AgNPs were characterized by dynamic light scattering and transmission electron microscopy. Inflammasome activation by AgNPs was measured after 6- and 24-hours incubations. AgNPs-induced inflammasome activation was significantly higher in the females, especially for the 6-hour exposure. No sex-based differences were observed for Ag ions controls. Younger donors exhibited significantly more inflammasome activation than older donors after 24-hours exposure. IL-10 was significantly suppressed in males and females after exposure. AgNPs suppressed leukocyte proliferation similarly in males and females. No chemoattractant effects, no alterations in plasma coagulation, or activation of the complement were observed after AgNPs exposure. In conclusion, the results highlight that there are distinct sex-based differences in inflammasome activation after exposure to AgNPs in human PBMCs. The results highlight the importance of considering sex-based differences in inflammasome activation induced by exposure to AgNPs in any future biocompatibility assessment for products containing AgNPs.
toxicology,nanoscience & nanotechnology